Clinical Trials Directory

Trials / Completed

CompletedNCT02296736

The Pre-operative Pathway in Pancreatic Head Malignancy-assessment of the Diagnostic Accuracy of Staging CT Scan

Status
Completed
Phase
Study type
Observational
Enrollment
422 (actual)
Sponsor
University Hospital Plymouth NHS Trust · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Our aim is to assess the ability of scans to distinguish the organ of origin of pancreatic head malignant tumours and to predict the resectability based on the preoperative imaging. To achieve this, a retrospective review of the preoperative CT scans will be conducted for all patients with pancreatic head malignancy treated at the Peninsula Hepato-Pancreatico-Biliary (HPB) cancer unit between January 2006 till January 2014.

Detailed description

Pancreatic cancer arises from the glandular part of the pancreas and is the fifth most common cause for cancer related death in the UK. It. Ampullary carcinoma arises from the epithelium of the ampulla of Vater into which the common bile duct and pancreatic duct drain. Cholangiocarcinoma arises from the bile duct epithelium, and may occur within the intra-pancreatic portion of the distal common bile duct mimicking a pancreatic malignancy. Cancers arising from these origins often cause obstructive jaundice and are hard to distinguish. Surgery is indicated for the treatment of these types of malignant tumours, and the definitive final diagnosis is usually not known until the specimen is examined. This situation does not allow specific treatment to be given pre-operatively, so-called 'neo-adjuvant therapy'. The rationale for this approach is that in a proportion of patients the tumour will be made smaller by this treatment, which may facilitate surgical resection.

Conditions

Interventions

TypeNameDescription
RADIATIONComputerised tomography (CT) scanRetrospective review of CT scans

Timeline

Start date
2014-10-01
Primary completion
2017-09-01
Completion
2017-09-01
First posted
2014-11-20
Last updated
2019-09-04

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02296736. Inclusion in this directory is not an endorsement.